The total return over the past 12 months is +11.31% vs. +16.94% for the S&P 500. So far it's up +74.98% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | +11.31% | +8.53% | (23.80%) | N/A | N/A | N/A |
| Total Return CAGR | +11.31% | +8.53% | (23.80%) | N/A | N/A | N/A |
| Revenue CAGR | +198.49% | N/A | N/A | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
RenovoRx, Inc. (RNXT)
| Year | Start price | End price | RNXT Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $0.84 | $1.47 | +74.98% | +14.51% | +60.47% |
| 2025 | $1.29 | $0.84 | (34.88%) | +17.72% | (52.60%) |
| 2024 | $2.29 | $1.29 | (43.67%) | +24.89% | (68.56%) |
| 2023 | $2.35 | $2.29 | (2.55%) | +26.19% | (28.74%) |
| 2022 | $4.84 | $2.35 | (51.45%) | (18.17%) | (33.28%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
